Michael A. Morse
- Oncology top 1%
- Pathology and Forensic Medicine top 2%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Co-authors
- Michael J. OvermanFabio GelsominoKa Yeung Mark WongBart NeynsThierry AndréSara LonardiAndrew HillScott Kopetz
- Topics
- Cancer Immunotherapy and Biomarkers (8 papers)Colorectal Cancer Treatments and Studies (7 papers)CAR-T cell therapy research (5 papers)
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
Michael A. Morse
21 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 1.8k
- Pathology and Forensic Medicine 650
- Immunology 465
- Pulmonary and Respiratory Medicine 432
- Cancer Research 365
Countries citing papers authored by Michael A. Morse
This map shows the geographic impact of Michael A. Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Morse more than expected).
Fields of papers citing papers by Michael A. Morse
This network shows the impact of papers produced by Michael A. Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Morse. The network helps show where Michael A. Morse may publish in the future.
Co-authorship network of co-authors of Michael A. Morse
This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Morse. A scholar is included among the top collaborators of Michael A. Morse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Morse. Michael A. Morse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142breakdown → | 154 |
| 4 | 22 | |
| 5 | Long Term Survival Following DeltaRex-G/DeltaVax Tumor-Targeted Gene Therapy for Advanced Chemotherapy-Resistant Malignancies: An Academic Milestone | 3 |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 77 | |
| 9 | Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancerbreakdown → | 1429 |
| 10 | 32 | |
| 11 | 27 | |
| 12 | 6 | |
| 13 | 33 | |
| 14 | 6 | |
| 15 | 4 | |
| 16 | 1 | |
| 17 | 24 | |
| 18 | 59 | |
| 19 | Technology evaluation: ipilimumab, Medarex/Bristol-Myers Squibb. | 42 |
| 20 | 162 |
About Michael A. Morse
Michael A. Morse is a scholar working on Oncology, Pathology and Forensic Medicine and Biotechnology, having authored 24 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (1.8k citations), Pathology and Forensic Medicine (650 citations) and Cancer Research (365 citations). Michael A. Morse has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Michael J. Overman, Fabio Gelsomino, Ka Yeung Mark Wong, Bart Neyns, Thierry André, Sara Lonardi, Andrew Hill, Scott Kopetz, Ray McDermott and Michael B. Sawyer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Surgery and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.